Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bristol-Myers Squibb Co (NYSE:BMY)

56.36
Delayed Data
As of Mar 22
 +0.65 / +1.17%
Today’s Change
46.01
Today|||52-Week Range
77.12
-3.56%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$93.2B

Company Description

Bristol-Myers Squibb Co. operates as a biopharmaceutical company, which engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of biopharmaceutical products. Its pharmaceutical products include chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY.

Contact Information

Bristol-Myers Squibb Co.
345 Park Avenue
New York New York 10154
P:(212) 546-4000
Investor Relations:

Employees

Shareholders

Mutual fund holders39.81%
Other institutional31.97%
Individual stakeholders0.39%

Top Executives

Giovanni CaforioChief Executive Officer & Director
Charles A. BancroftChief Financial Officer & Executive Vice President
Paul von AutenriedChief Information Officer & Senior Vice President
Francis M. CussChief Scientific Officer & Executive VP
Anne N. NielsenChief Compliance & Ethics Officer, Senior VP